INS and type 2 diabetes mellitus: From these data, prominent changes in Ca2+ handling, deposition of AGEs, and insulin metabolic signaling may influence cardiac interstitial fibrosis/fiber stiffness and diastolic dysfunction in T2D patients with HFpEF.